• SEVOFLURANE CHEMBL1200694 FDA Approved

    Alternate Names:

    Sevoflurane
    MR6S4
    Ultane
    Sojourn
    MR-6S4
    Sojourn Sevoflurane
    Sevorane AF
    Sevorane
    28523-86-6
    Sevofluran
    1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
    DB01236
    SEVOFLURANO
    F0691
    SEVOFLURANE [USAN:INN:BAN:JAN]
    AC1L1JU0
    PROPANE, 1,1,1,3,3,3-HEXAFLUORO-2-(FLUOROMETHOXY)-
    ETHER, FLUOROMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL-
    MR_6S4
    CID5206
    FLUOROMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER
    C009250
    LS-67851
    ZINC01530810
    SEVOFLURANO [INN-SPANISH]
    CHEBI:9130
    FLUOROMETHYL-2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER
    PC4681
    UNII-38LVP0K73A
    DAP000694
    NCGC00167421-01
    AC-15484
    SEVOFRANE
    D00547
    MOLPORT-001-775-746
    9723
    SEVOFLURANUM [INN-LATIN]
    BAX 3084
    FLUOROMETHYL 1,1,1,3,3,3-HEXAFLUOROISOPROPYL ETHER
    I14-13357
    C07520
    SEVOFLURANUM
    SEVOFLURANE (JAN/USAN/INN)
    C4H3F7O
    FLUOROMETHYL HEXAFLUOROISOPROPYL ETHER
    BRN 2041023
    5206
    ULTANE (TN)
    2,2,2-TRIFLUORO-1-(FLUOROMETHOXY)-1-(TRIFLUOROMETHYL)ETHANE
    1,1,1,3,3,3-HEXAKIS(FLUORANYL)-2-(FLUORANYLMETHOXY)PROPANE
    3B3-036212
    PROPANE,1,1,1,3,3,3-HEXAFLUORO-2-(FLUOROMETHOXY)-
    A819479
    K-7075
    FT-0605909
    TR-012574
    CAS-28523-86-6
    AB1010907
    SC-80759
    OR023816
    H752
    CJ-24036
    BC209166
    AK122513
    AJ-26696
    NCGC00167421-02
    SEVOFLURANE [USAN:USP:INN:BAN:JAN]
    RTR-012574
    RL02970
    NSC-760367
    CCG-213707
    AKOS007930500
    SBB092545
    NSC760367
    CS0059
    ANW-42890
    TOX21_112425
    ZINC1530810
    PHARMAKON1600-01503680
    HMS3264N21
    SEVOFLURANE (JP16/USAN/INN)
    CTK4G1651
    GTPL7296
    38LVP0K73A
    SCHEMBL61918
    DSSTOX_GSID_46614
    DSSTOX_RID_81767
    DSSTOX_CID_26614
    SOJOURN, ULTANE, SEVORANE
    PETREM
    ULTANEREG
    SOJOURNREG
    1H,1H,3H-PERFLUORO(3-METHYL-2-OXABUTANE)
    DFEYYRMXOJXZRJ-UHFFFAOYSA-N

    Drug Info:

    FDA Approval 1995
    Drug Class small molecule
    Drug Indications Anesthetics, Inhalation
    Drug Categories therapeutic uses
    Drug Categories qtc-prolonging agents (indeterminate risk and risk modifying)
    Drug Categories platelet aggregation inhibitors
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories organic chemicals
    Drug Categories nervous system
    Drug Categories hypotensive agents
    Drug Categories hydrocarbons, halogenated
    Drug Categories hematologic agents
    Drug Categories ethers
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories cytochrome p-450 cyp2e1 substrates
    Drug Categories cytochrome p-450 cyp2b6 substrates
    Drug Categories cytochrome p-450 cyp2a6 substrates
    Drug Categories chemical actions and uses
    Drug Categories central nervous system depressants
    Drug Categories central nervous system agents
    Drug Categories anesthetics, inhalation
    Drug Categories anesthetics, general
    Drug Categories anesthetics
    Drug Groups vet_approved
    Drug Groups approved
    Drug Type small molecule
    Drug Class anesthetics, inhalation
    Year of Approval 1995
    (2 More Sources)